Brii Biosciences Records Wider Loss in H1 on Nil Revenue

MT Newswires Live08-19

Brii Biosciences (HKG:2137) recorded a loss attributable to owners of 280.5 million yuan for the six months ended June 30, wider than 189.9 million yuan logged for the same period last year, a Monday filing with the Hong Kong Exchange said.

The company saw a loss per share of 0.38 yuan for the reporting period as compared to the 0.26 yuan per share from the year-ago period.

The company reported a nil revenue for the first half of this year due to the discontinuation of COVID-19 programs. It posted 617,000 yuan revenue in the year-ago period.

The company's shares were over 3% up on Monday's close.

Price (HKD): $0.98, Change: $+0.030, Percent Change: +3.16%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2460703641?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-19 20:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2460703641","market":"sh","top_or_hot":-1,"title":"Brii Biosciences Records Wider Loss in H1 on Nil Revenue","media":"MT Newswires Live","content":"<html><body><p> Brii Biosciences (HKG:2137) recorded a loss attributable to owners of 280.5 million yuan for the six months ended June 30, wider than 189.9 million yuan logged for the same period last year, a Monday filing with the Hong Kong Exchange said.</p><p>The company saw a loss per share of 0.38 yuan for the reporting period as compared to the 0.26 yuan per share from the year-ago period.</p><p>The company reported a nil revenue for the first half of this year due to the discontinuation of COVID-19 programs. It posted 617,000 yuan revenue in the year-ago period.</p><p>The company's shares were over 3% up on Monday's close.</p><p>Price (HKD): $0.98, Change: $+0.030, Percent Change: +3.16%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brii Biosciences Records Wider Loss in H1 on Nil Revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrii Biosciences Records Wider Loss in H1 on Nil Revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-19 20:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Brii Biosciences (HKG:2137) recorded a loss attributable to owners of 280.5 million yuan for the six months ended June 30, wider than 189.9 million yuan logged for the same period last year, a Monday ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02137","symbol_name":"腾盛博药-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2460703641","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2460703641","pubTimestamp":1724072313,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Brii Biosciences  recorded a loss attributable to owners of 280.5 million yuan for the six months ended June 30, wider than 189.9 million yuan logged for the same period last year, a Monday filing with the Hong Kong Exchange said.The company saw a loss per share of 0.38 yuan for the reporting period as compared to the 0.26 yuan per share from the year-ago period.The company reported a nil revenue for the first half of this year due to the discontinuation of COVID-19 programs. It posted 617,000 yuan revenue in the year-ago period.The company's shares were over 3% up on Monday's close.Price : $0.98, Change: $+0.030, Percent Change: +3.16%","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"02137":"腾盛博药-B"},"translate_title":"Brii Biosciences上半年亏损扩大，收入为零","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02137":0.9},"content_text":"Brii Biosciences (HKG:2137) recorded a loss attributable to owners of 280.5 million yuan for the six months ended June 30, wider than 189.9 million yuan logged for the same period last year, a Monday filing with the Hong Kong Exchange said.The company saw a loss per share of 0.38 yuan for the reporting period as compared to the 0.26 yuan per share from the year-ago period.The company reported a nil revenue for the first half of this year due to the discontinuation of COVID-19 programs. It posted 617,000 yuan revenue in the year-ago period.The company's shares were over 3% up on Monday's close.Price (HKD): $0.98, Change: $+0.030, Percent Change: +3.16%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460703641"}